Aveanna director granted 18,916 restricted shares

GANZI VICTOR F reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 02/17/2026 - 05:30 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

GANZI VICTOR F reported acquisition or exercise transactions in this Form 4 filing.

Aveanna Healthcare director Victor F. Ganzi reported an equity award of 18,916 common shares through a stock-settled restricted stock unit grant. The grant was made at a price of $0 per share and is subject to one-year cliff vesting. Following this award, Ganzi directly beneficially owns 502,522 shares of Aveanna Healthcare common stock.

Insider Trade Summary

Grant/Award: 18,916 shares

Grant/Award 1 txn

Insider GANZI VICTOR F

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.01 per share	18,916	$0.00	$0.00

Holdings After Transaction: Common Stock, par value $0.01 per share — 502,522 shares (Direct)

Footnotes (1)

1. F1. Grant of stock-settled restricted stock unit, subject to one-year cliff vesting.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Aveanna Healthcare (AVAH) disclose in this Form 4?

Aveanna Healthcare disclosed that director Victor F. Ganzi acquired 18,916 shares of common stock through a grant of stock-settled restricted stock units. The award was recorded at $0 per share and represents a non-cash equity compensation grant rather than an open-market stock purchase.

Who is the reporting person in the Aveanna Healthcare (AVAH) Form 4 filing?

The reporting person is Victor F. Ganzi, who serves as a director of Aveanna Healthcare Holdings, Inc. The Form 4 shows his role as director and reports his direct beneficial ownership of company common stock following the latest equity award transaction disclosed in the filing.

How many Aveanna Healthcare (AVAH) shares did Victor Ganzi acquire and at what price?

Victor Ganzi acquired 18,916 shares of Aveanna Healthcare common stock via a restricted stock unit grant. The filing shows a transaction price of $0 per share, indicating the award was part of equity compensation and not an open-market purchase funded with cash consideration.

What are the vesting terms of Victor Ganzi’s new Aveanna Healthcare (AVAH) RSU grant?

The grant consists of stock-settled restricted stock units that are subject to one-year cliff vesting. This means the entire 18,916-share award is scheduled to vest at the end of a one-year period, rather than vesting gradually in smaller installments over multiple dates.

What is Victor Ganzi’s total Aveanna Healthcare (AVAH) share ownership after this transaction?

After the reported restricted stock unit grant, Victor Ganzi beneficially owns 502,522 shares of Aveanna Healthcare common stock directly. This figure, shown in the Form 4, reflects his total direct holdings immediately following the 18,916-share stock-based compensation award on February 14, 2026.

Was the Aveanna Healthcare (AVAH) Form 4 transaction a stock purchase or compensation grant?

The transaction was a compensation grant, not a market purchase. The Form 4 identifies the code as a grant, award, or other acquisition, and the footnote describes it as stock-settled restricted stock units with one-year cliff vesting, recorded at $0 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GANZI VICTOR F

(Last) (First) (Middle)

C/O AVEANNA HEALTHCARE HOLDINGS INC.

400 INTERSTATE NORTH PARKWAY SE

(Street)

ATLANTA GA 30339

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/14/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	02/14/2026		A		18,916(1)	A	$0	502,522	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock-settled restricted stock unit, subject to one-year cliff vesting.

	/s/ Jonathan Beckler, Attorney-in-Fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.